Overview and Scope
Panuveitis is a severe inflammation of all layers of the eye’s uvea, including the iris, ciliary body, and choroid, which can affect the retina, vitreous humor, optic nerve, or eye lens. Panuveitis treatment is essential to reduce inflammation, alleviate symptoms, and prevent vision loss or complications associated with the disease.
Sizing and Forecast
The panuveitis treatment market size has grown rapidly in recent years. It will grow from $3.6 billion in 2023 to $3.98 billion in 2024 at a compound annual growth rate (CAGR) of 10.7%. The growth in the historic period can be attributed to increased prevalence of uveitis, increased awareness and early diagnosis, improved drug delivery systems, patient advocacy initiatives, government support and regulatory approvals..
The panuveitis treatment market size is expected to see strong growth in the next few years. It will grow to $5.74 billion in 2028 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to personalized medicine approaches, emerging therapeutic modalities, focus on patient-centric care, global health preparedness, precision medicine initiatives, healthcare policy changes.. Major trends in the forecast period include combination therapies for synergistic effects, telemedicine and remote monitoring, advancements in imaging technologies, integration of artificial intelligence, global collaborations in research..
Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/panuveitis-treatment-global-market-report
Segmentation & Regional Insights
The panuveitis treatment market covered in this report is segmented –
1) By Drug Class: Anti-Inflammatory, Antimicrobial Drugs, Immunotherapy And Targeted Therapies
2) By Route of Administration: Oral, Topical
3) By End Users: Hospitals, Home Care, Specialty Clinics, Other End Users
North America was the largest region in the panuveitis treatment market in 2023. The regions covered in the panuveitis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13157&type=smp
Major Driver Impacting Market Growth
The increasing prevalence of eye-related diseases is expected to propel the growth of the panuveitis treatment market going forward. Eye-related diseases, also known as ocular diseases or eye conditions, are medical conditions that affect the health and function of the eyes. Panuveitis treatment reduces inflammation, prevents complications, and improves the quality of life for patients suffering from eye diseases. For instance, in December 2022, according to the Centers for Disease Control and Prevention (CDC), a US-based public health agency, 20.5 million Americans over 40 had at least one cataract. Additionally, it is anticipated that approximately 30 million people will have cataract eye disease by 2028. Therefore, the increasing prevalence of eye-related diseases drives the panuveitis treatment market.
Key Industry Players
Major companies operating in the panuveitis treatment market report are Pfizer Inc., Johnson and Johnson Pvt. Ltd., Bausch Health Companies Inc., AbbVie Inc., Novartis AG, Bristol-Myers Squibb Company, Hoffmann-La Roche Ltd., Allergan Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Daiichi Sankyo Company Ltd., Horizon Therapeutics plc, Hikma Pharmaceuticals PLC, Santen Pharmaceutical Co. Ltd., Jubilant Life Sciences Ltd., HanAll Biopharma Inc., Xbrane Biopharma AB, Alimera Science Inc., Ocular Therapeutix Inc., EyeGate Pharmaceuticals Inc., Eyepoint Pharmaceuticals Inc., Graybug Vision Inc., Xoma Corporation, Tarsier Pharma Ltd., Vintage Labs Pvt. Ltd., Icon Bioscience Inc., Aciont Inc., Clearside Biomedical Inc., Aldeyra Therapeutics Inc.
The panuveitis treatment market report table of contents includes:
1. Executive Summary
2. Panuveitis Treatment Market Characteristics
3. Panuveitis Treatment Market Trends And Strategies
4. Panuveitis Treatment Market – Macro Economic Scenario
5. Global Panuveitis Treatment Market Size and Growth
.
.
.
32. Global Panuveitis Treatment Market Competitive Benchmarking
33. Global Panuveitis Treatment Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Panuveitis Treatment Market
35. Panuveitis Treatment Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
